Global Alliance for Chronic Diseases (GACD)
Launch of the GACD Diabetes Research Programme Report
Report
06 Nov 2024
This report examines the achievements of national and regional NCD alliances during the second phase of the Advocacy Institute (2020-2023).
The second phase of the Advocacy Institute (2020-2023) supported a total of 16 geographies as part of a Seed programme and two thematic Accelerator programmes (one focused on prevention and one focused on NCDs and UHC). The programmes supported alliances via a combination of grants; technical assistance; peer-to-peer learning, training and capacity building workshops; and ensuring linkages between global, regional and national advocacy work.
The second phase of the Advocacy Institute demonstrated the vital role of NCDA’s capacity development work. Ninety-three per cent of the participating alliances reported to have strengthened their governance and undertaken a strategic planning process to identify clear organisational objectives and advocacy priorities. Similarly, 86% indicated that they had gained a clear understanding of national NCD policies and processes, and 73% of alliances highlighted positioning their alliances as a legitimate, respected, credible and strong civil society voice on NCDs.
Thanks to the achievements and the lessons learned during both the first (2017- 2019) and second phase (2020-2023), the Advocacy Institute remains a flagship initiative of the NCDA’s capacity development work with demonstrated impact for NCD alliances in low- and middle-income countries. Looking ahead, the NCD Alliance will continue building capacity and strengthening advocacy efforts towards more advocacy gains and wins during an upcoming third phase.